New Survey Reveals That Low Sexual Desire Disrupts Relationships

[title]

Nearly one in two non-menopausal women ages 30 to 50 say they have experienced low sexual desire at some point in their lives, and many of these women (61 percent) felt distressed by it, according to a new national survey.

Low sexual desire that is accompanied by distress and strains a woman's relationship with her partner may be signs of a common type of female sexual dysfunction known as hypoactive sexual desire disorder, or HSDD. Yet, while most women were aware of erectile dysfunction and other men's sexual health issues, only 14 percent of those surveyed, including women with symptoms of low desire, were aware of HSDD, which has been a medical diagnosis for over 30 years. The survey, launched today as part of Women's Health Month, was supported by HealthyWomen and Palatin Technologies, Inc., which is developing an on-demand treatment for HSDD.

"Sex is an important part of a romantic relationship, so a lack of intimacy can sometimes create tension within an otherwise healthy partnership," said Beth Battaglino, R.N., CEO and President of HealthyWomen. "Women who avoid sex because of low sexual desire may not realize that this could be a sign of a medical issue. Most women don't know what female sexual dysfunction is nor do they understand that conditions like HSDD are real and can be a serious concern for them as well as their partner."

Indeed, most of the women surveyed said low sexual desire would hurt the level of intimacy with their romantic partner (85 percent) and impair communication (66 percent). Among those respondents who report experiencing low desire or who self-identified with HSDD, nearly half (45 percent) blame themselves and 38 percent admit that it makes them question their worth in the relationship.

Currently, there are no drugs in the United States approved for the treatment of HSDD. According to the survey, most women (87 percent) believe there should be a treatment available but are not aware of any treatment options for the condition. More women would be interested in a treatment taken "on-demand" or when needed for sexual activity as opposed to a daily pill (58 percent vs. 42 percent, respectively). Among those who self-identified with HSDD, nearly all (92 percent) said they would be interested in HSDD treatment; 75 percent said they are frustrated that one is not yet available. 

"It is important for women living with HSDD or some other form of female sexual dysfunction to not blame themselves and feel confident to discuss their concerns with their healthcare provider and their partner," Battaglino said. "At HealthyWomen, we support the ongoing research in female sexual health focused on providing women with access to safe and effective therapies."

 


SOURCE Palatin Technologies, Inc.